Scancell (SCLP) Competitors GBX 13.25 -0.25 (-1.85%) (As of 11/29/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines SCLP vs. SLN, OXB, PRTC, HZD, VRP, BVXP, ARIX, AVCT, 4BB, and FARNShould you be buying Scancell stock or one of its competitors? The main competitors of Scancell include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), Avacta Group (AVCT), 4basebio (4BB), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. Scancell vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience Avacta Group 4basebio Faron Pharmaceuticals Oy Silence Therapeutics (LON:SLN) and Scancell (LON:SCLP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Do insiders and institutionals hold more shares of SLN or SCLP? 46.5% of Scancell shares are held by institutional investors. 5.0% of Scancell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor SLN or SCLP? In the previous week, Silence Therapeutics' average media sentiment score of 0.00 equaled Scancell'saverage media sentiment score. Company Overall Sentiment Silence Therapeutics Neutral Scancell Neutral Does the MarketBeat Community prefer SLN or SCLP? Silence Therapeutics received 16 more outperform votes than Scancell when rated by MarketBeat users. However, 74.50% of users gave Scancell an outperform vote while only 68.81% of users gave Silence Therapeutics an outperform vote. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% ScancellOutperform Votes18774.50% Underperform Votes6425.50% Which has stronger valuation & earnings, SLN or SCLP? Silence Therapeutics has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/AScancell£5.27M23.37-£5.86M-£0.01-1,325.00 Is SLN or SCLP more profitable? Silence Therapeutics' return on equity of 0.00% beat Scancell's return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Scancell N/A -269.84%-45.28% SummarySilence Therapeutics beats Scancell on 5 of the 9 factors compared between the two stocks. Ad Weiss Ratings***TODAY ONLY*** Nvidia’s Next AI PlayThanks to a specific AI Blueprint … A small handful of companies have already soared as much as 562%, 3,247% and even 6,583%. Now, with a massive recent $1 trillion pivot to data centers, six NEW stocks could be next in line to follow this pattern.Today only, the 2025 AI Blueprint has been revealed … Get Scancell News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLP vs. The Competition Export to ExcelMetricScancellBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£123.17M£143.00M£5.55B£1.59BDividend YieldN/A3.47%5.36%7.13%P/E Ratio-1,325.00273.5575.381,724.35Price / Sales23.3719,396.271,304.93252,649.66Price / Cash7.8612.4244.5826.32Price / BookN/A8.267.432.89Net Income-£5.86M-£20.51M£120.35M£167.60M7 Day Performance-5.36%1.88%3.95%0.33%1 Month Performance-0.93%9.13%1.59%-0.65%1 Year Performance18.30%27.26%36.88%29.02% Scancell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLPScancellN/AGBX 13.25-1.9%N/A+20.7%£123.17M£5.27M-1,325.0051Gap DownSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford BiomedicaN/AGBX 426.25+1.5%GBX 433.33+1.7%+156.9%£449.10M£97.28M-295.14891High Trading VolumePRTCPureTech HealthN/AGBX 172+0.5%N/A+8.7%£411.80M£3.33M-735.65300High Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/A+0.0%£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/AN/A£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,756.50-1.0%N/A-3.9%£196.09M£13.60M2,304.6012Positive NewsARIXArix BioscienceN/AGBX 142flatN/AN/A£183.73M£14.16M1,290.919AVCTAvacta GroupN/AGBX 49.67+1.4%N/A-64.8%£177.97M£22.62M-551.89120Gap Up4BB4basebioN/AGBX 1,262.50+0.6%N/A+130.1%£161.73M£311,000.00-1,666.67101Positive NewsGap UpFARNFaron Pharmaceuticals OyN/AGBX 154.50+7.5%N/A-37.0%£161.64M£-725,000.00-468.7534Gap Down Related Companies and Tools Related Companies SLN Competitors OXB Competitors PRTC Competitors HZD Competitors VRP Competitors BVXP Competitors ARIX Competitors AVCT Competitors 4BB Competitors FARN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SCLP) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scancell Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Scancell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCLP Stock Alerts